Literature DB >> 14727223

Nutritionally variant streptococcal infections at a University Hospital in Taiwan: disease emergence and high prevalence of beta-lactam and macrolide resistance.

Chung-Hsin Liao1, Lee-Jene Teng, Po-Ren Hsueh, Yu-Chi Chen, Li-Min Huang, Shan-Chwen Chang, Shen-Wu Ho.   

Abstract

From January 1993 to December 2002, 28 patients with nutritionally variant streptococci (NVS) infections were treated at a university hospital in Taiwan. Twelve (43%) of these patients had various underlying malignancies, and 7 (25%) had underlying valvular heart diseases. Nine patients (32%) had infective endocarditis, and 9 (32%) had primary bacteremia. The deaths of 7 patients (25%) were directly related to NVS infection. Among the 28 isolates recovered from these patients, 50% were not susceptible to penicillin, 33% were not susceptible to cefotaxime, and 93% were not susceptible to azithromycin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14727223     DOI: 10.1086/381098

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Antimicrobial susceptibilities of invasive pediatric Abiotrophia and Granulicatella isolates.

Authors:  Xiaotian Zheng; Alexandra F Freeman; Jay Villafranca; Dee Shortridge; Jill Beyer; William Kabat; Karen Dembkowski; Stanford T Shulman
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Antimicrobial Susceptibility Patterns among a Large, Nationwide Cohort of Abiotrophia and Granulicatella Clinical Isolates.

Authors:  Kunatum Prasidthrathsint; Mark A Fisher
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

3.  Use of groESL as a target for identification of Abiotrophia, Granulicatella, and Gemella species.

Authors:  Wei-Chun Hung; Sung-Pin Tseng; Hsiao-Jan Chen; Jui-Chang Tsai; Chih-Hsin Chang; Tai-Fen Lee; Po-Ren Hsueh; Lee-Jene Teng
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

4.  Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans.

Authors:  Michael O Alberti; Janet A Hindler; Romney M Humphries
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

5.  Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva.

Authors:  Ammara Mushtaq; Kerryl E Greenwood-Quaintance; Nicolynn C Cole; Peggy C Kohner; Sherry M Ihde; Gregory J Strand; Lance W Harper; Abinash Virk; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Endocarditis caused by Abiotrophia defectiva.

Authors:  Asma M Al-Jasser; Mushira A Enani; Mohammed R Al-Fagih
Journal:  Libyan J Med       Date:  2007-03-01       Impact factor: 1.657

7.  Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species.

Authors:  Laurence Senn; José M Entenza; Gilbert Greub; Katia Jaton; Aline Wenger; Jacques Bille; Thierry Calandra; Guy Prod'hom
Journal:  BMC Infect Dis       Date:  2006-01-20       Impact factor: 3.090

8.  Nutritionally variant streptococci bacteremia in cancer patients: a retrospective study, 1999-2014.

Authors:  Abraham T Yacoub; Jayasree Krishnan; Ileana M Acevedo; Joseph Halliday; John N Greene
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-04-20       Impact factor: 2.576

9.  Oral microbiota distinguishes acute lymphoblastic leukemia pediatric hosts from healthy populations.

Authors:  Yan Wang; Jing Xue; Xuedong Zhou; Meng You; Qin Du; Xue Yang; Jinzhi He; Jingzhi He; Jing Zou; Lei Cheng; Mingyun Li; Yuqing Li; Yiping Zhu; Jiyao Li; Wenyuan Shi; Xin Xu
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

10.  An unusual case of thoracic empyema caused by Granulicatella elegans (nutritionally variant streptococci) in a patient with pulmonary tuberculosis and human immunodeficiency virus infection.

Authors:  Nomonde R Mvelase; Kanitha Marajh; Olga Hattingh; Koleka P Mlisana
Journal:  JMM Case Rep       Date:  2016-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.